| Disparities in prostate cancer incidence and mortality rates: Solvable or not? S Badal, W Aiken, B Morrison, H Valentine, S Bryan, A Gachii, C Ragin The Prostate 80 (1), 3-16, 2020 | 44 | 2020 |
| Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase Z Zhao, H Fowle, H Valentine, Z Liu, Y Tan, J Pei, S Badal, JR Testa, ... Prostate cancer and prostatic diseases 24 (1), 233-243, 2021 | 14 | 2021 |
| The need for cell lines from diverse ethnic backgrounds for prostate cancer research S Badal, KS Campbell, H Valentine, C Ragin Nature Reviews Urology 16 (12), 691-692, 2019 | 12 | 2019 |
| ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer Y Zhou, J Börcsök, E Adib, SC Kamran, AJ Neil, K Stawiski, D Freeman, ... Science Advances 9 (47), eadg2263, 2023 | 3 | 2023 |
| Role of gut microbiome in neoadjuvant chemotherapy response in urothelial carcinoma: a multi-institutional prospective cohort evaluation L Bukavina, R Ginwala, M Sindhani, M Prunty, D Geynisman, G Pooja, ... bioRxiv, 2023.01. 21.525021, 2023 | 3 | 2023 |
| Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient H Valentine, W Aiken, B Morrison, Z Zhao, H Fowle, JS Wasserman, ... Cancer research communications 2 (11), 1355-1371, 2022 | 3 | 2022 |
| Cancer associated fibroblast dependency in a model of bladder cancer H Valentine, U Satyal, L Bukavina, H Uddin, Y Benyamin, R Arya, ... Cancer Research 84 (6_Supplement), 1436-1436, 2024 | | 2024 |
| Urine-based liquid biopsy test for the detection of residual bladder cancer in radical cystectomy patients R Arya, H Valentine, U Satyal, R Chelluri, M Li, P Abbosh Cancer Research 84 (6_Supplement), 3701-3701, 2024 | | 2024 |
| A COMPARISON BETWEEN ULTRASOUND IMAGING AND CT FOR BBN-DRIVEN BLADDER CANCER MOUSE MODEL T Sholklapper, L Bukavina, Q Cai, H Valentine, A Kutikov, Y Yang, ... Urologic Oncology: Seminars and Original Investigations 42, S39, 2024 | | 2024 |
| EVALUATING THE EFFICACY OF INTRAVESICAL LACTOBACILLUS RHAMNOSUS GG AS A NOVEL THERAPEUTIC APPROACH IN BBN MURINE MODEL OF BLADDER CANCER E Helstrom, H Valentine, R Chelluri, A Kutikov, R Uzzo, P Abbosh, ... Urologic Oncology: Seminars and Original Investigations 42, S48-S49, 2024 | | 2024 |
| Current Trends and Challenges of Microbiome Research in Bladder Cancer I Isali, EK Helstrom, N Uzzo, A Lakshmanan, D Nandwana, H Valentine, ... Current Oncology Reports, 1-7, 2024 | | 2024 |
| Cancer-associated fibroblasts potentiate subcutaneous tumor growth in a novel bladder cancer mouse model with a genotype dependency HL Valentine, U Satyal, A Metz, L Bukavina, PH Abbosh Cancer Research 83 (7_Supplement), 2884-2884, 2023 | | 2023 |
| Identification of intratumor pathogens from single-cell RNA sequencing, cellular dysfunction and immune response L Bukavina, M Sindhani, H Valentine, D Ranti, K Mishra, A Kutikov, ... Cancer Research 83 (7_Supplement), 5891-5891, 2023 | | 2023 |
| Macrophage transcriptomic signature validation in scRNA seq and overall survival differences in urothelial carcinoma L Bukavina, S Bell, D Geynisman, I Isali, D Ranti, J Sfakianos, H Valentine, ... Cancer Research 83 (7_Supplement), 5141-5141, 2023 | | 2023 |
| PD25-12 IDENTIFICATION OF INTRATUMOR PATHOGENS FROM SINGLE-CELL RNA SEQUENCING, CELLULAR DYSFUNCTION AND IMMUNE RESPONSE L Bukavina, M Sindhani, H Valentine, D Ranti, K Mishra, A Kutikov, ... The Journal of Urology 209 (Supplement 4), e734, 2023 | | 2023 |
| PD25-01 MACROPHAGE TRANSCRIPTOMIC SIGNATURE VALIDATION IN SCRNA SEQ AND OVERALL SURVIVAL DIFFERENCES IN UROTHELIAL CARCINOMA L Bukavina, I Safder, S Bell, D Geynishman, I Isali, D Ranti, J Sfakianos, ... The Journal of Urology 209 (Supplement 4), e729, 2023 | | 2023 |
| Second generation imidazolium compounds as tumor-specific intravesical therapeutic agents for non-muscle invasive bladder cancer U Satyal, D Weader, H Valentine, M Stromyer, WJ Youngs, PH Abbosh Cancer Research 82 (12_Supplement), 4058-4058, 2022 | | 2022 |
| Development of customizable bladder cancer mouse model using CRISPR HL Valentine, U Satyal, PH Abbosh Cancer Research 82 (12_Supplement), 942-942, 2022 | | 2022 |
| Abstract PO-138: The first Caribbean cell line, a prostate cancer cell line: ACRJ-PC28 H Valentine, W Aiken, B Morrison, Z Zhao, H Fowle, JS Wasserman, ... Cancer Epidemiology, Biomarkers & Prevention 31 (1_Supplement), PO-138-PO-138, 2022 | | 2022 |
| The culture and propagation of a novel Jamaican prostate cell line HL Valentine | | 2020 |
